Ningbo Menovo Pharmaceutical Co.Ltd(603538) : audit report of Zhejiang Liaoyuan Pharmaceutical Co., Ltd. (2021)

Ningbo Menovo Pharmaceutical Co.Ltd(603538) : audit report of Zhejiang Liaoyuan Pharmaceutical Co., Ltd. (2021) I. audit opinion we have audited the financial statements of Zhejiang Liaoyuan Pharmaceutical Co., Ltd. (hereinafter referred to as Liaoyuan pharmaceutical), including the balance sheet as of December 31, 2021, the income statement, cash flow statement, statement of changes in owner’s equity and notes to relevant financial statements in 2021. In our opinion, the attached financial statements have been prepared in accordance with the accounting standards for business enterprises in all major aspects, and fairly reflect the financial position of Liaoyuan pharmaceutical as of December 31, 2021 and the operating results and cash flow in 2021. II. The basis for forming audit opinions. We have carried out the audit work in accordance with the audit standards for Chinese certified public accountants. The “responsibilities of certified public accountants for the audit of financial statements part of the audit report further describes our responsibilities under these standards. According to the code of professional ethics of Chinese certified public accountants, we are independent of Liaoyuan pharmaceutical and have fulfilled other responsibilities in terms of professional ethics. We believe that the audit evidence we have obtained is sufficient and appropriate, which provides a basis for our audit opinion